Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mersina
- Development stage
- Phase 2
- Lead developer
- Jyoti Clinical and Pathological Laboratory
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Mersina is a proprietary Ayurvedic polyherbal formulation developed for the management of Type 2 diabetes mellitus (T2DM). It is specifically indicated for patients who have experienced secondary failure with conventional oral hypoglycemic agents. The formulation consists of a complex blend of traditional medicinal plants, including *Gymnema sylvestre* (Gudmar), *Pterocarpus marsupium* (Bijasar), *Momordica charantia* (Karela), and *Eugenia jambolana* (Jamun), which are recognized in Ayurvedic medicine for their hypoglycemic and insulin-sensitizing properties. Mersina is believed to lower blood glucose levels through multiple mechanisms, such as stimulating insulin secretion from pancreatic beta cells, improving peripheral glucose utilization, and inhibiting intestinal glucose absorption. It has been evaluated in clinical trials to assess its safety and efficacy as an adjunct or alternative therapy in diabetic patients.
- Brand names
- Mersina
- Other names
- Mersina CapsuleMersina Ayurvedic Formulation
02
Targets
Sucrase-IsomaltaseINSR (Insulin receptor)
Beyond the preview
Go deeper on Mersina.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mersina.